by Sue Robbins | Jul 15, 2019 | Migraine
Research in an animal model of headache suggests that different underlying mechanisms at work in migraine may explain why some calcitonin gene-related peptide inhibitors, such as fremanezumab, may not work for everyone. Read more here.
by Sue Robbins | Jul 10, 2019 | Migraine
Antiepileptic drugs (AEDs) are frequently used as a preventive treatment for the management of migraine. Topiramate (TPM) and valproic acid (VPA) are 2 AEDs that have demonstrated efficacy in reducing the frequency of migraine attacks. Read more here.
by Sue Robbins | Jul 9, 2019 | Migraine
Despite the availability of new therapies, the vast majority of people with migraine headache receive inadequate treatment. A 2013 study by Lipton et al1proposed 3 steps to achieving minimally effective pharmacologic therapy for acute and chronic migraine. Read more...
by Sue Robbins | Jul 8, 2019 | Migraine
While some light can worsen episodes, green light may ease them Read more here.
by Sue Robbins | Jul 7, 2019 | Migraine
Migraine in children and adolescents remains underrecognized and underdiagnosed due to challenges like nonspecific symptoms, poor articulation of symptoms from patients, and lack of awareness of the prevalence of migraine in these populations. Read more...
